Toru Seo active positions
Companies | Position | Start | End |
---|---|---|---|
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Director/Board Member | - | - |
HISHOH Biopharma Co., Ltd.
HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Founder | 2021-04-11 | - |
Corporate Officer/Principal | 2021-04-11 | - |
Career history of Toru Seo
Training of Toru Seo
Wake Forest University | Doctorate Degree |
Statistics
International
Japan | 3 |
United States | 2 |
Operational
Director/Board Member | 1 |
Doctorate Degree | 1 |
Founder | 1 |
Sectoral
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cellusion Inc.
Cellusion Inc. Miscellaneous Commercial ServicesCommercial Services Cellusion Inc. is a Japanese company that focuses on regenerating corneal endothelium using IPS cells to treat bullous keratopathy. The company is based in Tokyo, Japan. The company was founded in 2015 by Shigeto Shimmura, Kazuo Tsubota, Shin Hatou. | Commercial Services |
HISHOH Biopharma Co., Ltd.
HISHOH Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services HISHOH Biopharma Co., Ltd. is a Japanese company that develops allergen immunotherapy. The company was founded in 2021 by Toru Seo and Naoki Sakurai. Naoki Sakurai has been the CEO since 2021. | Commercial Services |
- Stock Market
- Insiders
- Toru Seo
- Experience